0000000000964198

AUTHOR

G. Perugi

showing 2 related works from this author

PMH2 Treatment Outcomes for Patients with Treatment Resistant Depression in European Standard Clinical Practice

2020

Clinical Practicemedicine.medical_specialtybusiness.industryHealth PolicyTreatment outcomePublic Health Environmental and Occupational HealthmedicineEuropean standardmedicine.diseaseIntensive care medicinebusinessTreatment-resistant depressionValue in Health
researchProduct

Real-world evidence from a European cohort study of patients with treatment resistant depression: Baseline patient characteristics: Patient character…

2021

Background: Treatment resistant depression (TRD; failure to respond to ≥2 treatments) affects ~20% of patients with major depressive disorder (MDD). Real-world data could help describe patient characteristics and TRD disease burden, to assess the unmet needs of TRD patients in Europe. Methods: This observational study collected data from adults with moderate to severe TRD initiating a new treatment for depression, according to local standards of care. At baseline, socio-demographic characteristics, medical history, prior and current treatments were recorded. Disease severity, health-related quality of life (HRQoL), functionality and productivity were assessed. Results: Overall, 411 eligible…

Disease burden; Health-related quality of life; Major depressive disorder; Observational study; Patient-reported outcomes; Socio-economic statusPatient-reported outcomesHealth-related quality of lifeObservational studySocio-economic statusDisease burdenMajor depressive disorderPsiquiatria
researchProduct